Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2019, Article ID 8036863, 13 pages
https://doi.org/10.1155/2019/8036863
Research Article

Interaction of Mitoxantrone-Loaded Cholesterol Modified Pullulan Nanoparticles with Human Serum Albumin and Effect on Drug Release

1Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha 410013, China
2Department of Pharmacology, Hubei University of Medicine, Shiyan, Hubei 442000, China

Correspondence should be addressed to Xiaojun Tao; moc.621@oatjoaix and Qiufang Zhang; moc.361@0002111fqz

Received 10 December 2018; Revised 17 March 2019; Accepted 15 April 2019; Published 16 May 2019

Academic Editor: Surinder Singh

Copyright © 2019 Liming Yuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Nam, S. Y. Kim, and H. Seong, “Investigation on physicochemical characteristics of a nanoliposome-based system for dual drug delivery,” Nanoscale Research Letters, vol. 13, no. 1, pp. 101–112, 2018. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Yan, A. Li, A. Zhang, Y. Sun, and J. Liu, “Polymer-based nanocarriers for co-delivery and combination of diverse therapies against cancers,” Nanomaterials, vol. 8, no. 2, pp. 85–112, 2018. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Shi, P. W. Kantoff, R. Wooster, and O. C. Farokhzad, “Cancer nanomedicine: progress, challenges and opportunities,” Nature Reviews. Cancer, vol. 17, no. 1, pp. 20–37, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Roy, H. Ding, S. Pilakka Kanthikeel et al., “Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue,” International Journal of Nanomedicine, vol. 10, no. 1, pp. 5819–5835, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. P. Calatayud, B. Sanz, V. Raffa, C. Riggio, M. R. Ibarra, and G. F. Goya, “The effect of surface charge of functionalized Fe3O4 nanoparticles on protein adsorption and cell uptake,” Biomaterials, vol. 35, no. 24, pp. 6389–6399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Giri, M. S. Diallo, A. J. Simpson et al., “Interactions of poly(amidoamine) dendrimers with human serum albumin: binding constants and mechanisms,” ACS Nano, vol. 5, no. 5, pp. 3456–3468, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Tao, S. Jin, D. Wu et al., “Effects of particle hydrophobicity, surface charge, media pH value and complexation with human serum albumin on drug release behavior of mitoxantrone-loaded pullulan nanoparticles,” Nanomaterials (Basel), vol. 6, no. 1, p. 2, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Zhang, Y. Moustafa, and Q. Huo, “Different interaction modes of biomolecules with citrate-capped gold nanoparticles,” ACS Applied Materials & Interfaces, vol. 6, no. 23, pp. 21184–21192, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-J. Hu, Y. Ou-Yang, C.-M. Dai, Y. Liu, and X.-H. Xiao, “Site-selective binding of human serum albumin by palmatine: spectroscopic approach,” Biomacromolecules, vol. 11, no. 1, pp. 106–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Ghuman, P. A. Zunszain, I. Petitpas, A. A. Bhattacharya, M. Otagiri, and S. Curry, “Structural basis of the drug-binding specificity of human serum albumin,” Journal of Molecular Biology, vol. 353, no. 1, pp. 38–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. McCallum, A. J. Pawlak, W. R. Shadrick et al., “A fluorescence-based high throughput assay for the determination of small molecule-human serum albumin protein binding,” Analytical and Bioanalytical Chemistry, vol. 406, no. 7, pp. 1867–1875, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. X. Fu, K. W. Wang, Y. S. Ge et al., “Biophysical studies of the interaction between a triazole derivative and bovine serum albumin by multi-spectroscopic and molecular modeling methods,” Science China Chemistry, vol. 54, no. 5, pp. 788–796, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Huang, H. Qiu, J. Xie et al., “Systematical investigation of in vitro molecular interaction between fluorescent carbon dots and human serum albumin,” RSC Advances, vol. 6, no. 50, pp. 44531–44542, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Ruan, L. Liu, Y. Lu et al., “Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma,” Acta Pharmaceutica Sinica B, vol. 8, no. 1, pp. 85–96, 2018. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Zhang, B. J. Niebuur, P. Chytil et al., “Macromolecular pHPMA-based nanoparticles with cholesterol for solid tumor targeting: behavior in HSA protein environment,” Biomacromolecules, vol. 19, no. 2, pp. 470–480, 2018. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Ghosh, J. Patwari, and S. Dasgupta, “Complexation with human serum albumin facilitates sustained release of morin from polylactic-co-glycolic acid nanoparticles,” Journal of Physical Chemistry B, vol. 121, no. 8, pp. 1758–1770, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Szwed, “Mitoxantrone - an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis,” Postȩpy Higieny i Medycyny Doświadczalnej (Online), vol. 68, pp. 198–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Akiyoshi, T. Nishikawa, Y. Mitsui, T. Miyata, M. Kodama, and J. Sunamoto, “Self-assembly of polymer amphiphiles: thermodynamics of complexation between bovine serum albumin and self-aggregate of cholesterol-bearing pullulan,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 112, no. 2-3, pp. 91–95, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. R. S. Singh, N. Kaur, and J. F. Kennedy, “Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting,” Carbohydrate Polymers, vol. 123, pp. 190–207, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Li, S. Bian, Y. Huang, J. Liang, Y. Fan, and X. Zhang, “High drug loading pH-sensitive pullulan-DOX conjugate nanoparticles for hepatic targeting,” Journal of Biomedical Materials Research Part A, vol. 102, no. 1, pp. 150–159, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. G. Antoniraj, M. Ayyavu, L. J. K. Henry et al., “Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery,” Drug Development and Industrial Pharmacy, vol. 44, no. 3, pp. 365–376, 2018. View at Publisher · View at Google Scholar · View at Scopus
  22. S. N. Khan, B. Islam, R. Yennamalli, A. Sultan, N. Subbarao, and A. U. Khan, “Interaction of mitoxantrone with human serum albumin: spectroscopic and molecular modeling studies,” European Journal of Pharmaceutical Sciences, vol. 35, no. 5, pp. 371–382, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Tao, T. Tao, Y. Wen et al., “Novel delivery of mitoxantrone with hydrophobically modified pullulan nanoparticles to inhibit bladder cancer cell and the effect of nano-drug size on inhibition efficiency,” Nanoscale Research Letters, vol. 13, no. 1, 2018. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Yang, H.-l. Chen, F.-p. Gao et al., “Self-aggregated nanoparticles of cholesterol-modified pullulan conjugate as a novel carrier of mitoxantronep,” Current Nanoscience, vol. 6, no. 3, pp. 298–306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. L. Zhang, Y. X. Liu, X. M. Zhang et al., “Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids,” Materials Science and Engineering: C, vol. 91, pp. 414–425, 2018. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Beigoli, A. Sharifi Rad, A. Askari, R. Assaran Darban, and J. Chamani, “Isothermal titration calorimetry and stopped flow circular dichroism investigations of the interaction between lomefloxacin and human serum albumin in the presence of amino acids,” Journal of Biomolecular Structure & Dynamics, vol. 37, no. 9, pp. 2265–2282, 2018. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Cong, J. Bi, X. Song, C. Yu, and M. Tan, “Ultrasmall fluorescent nanoparticles derived from roast duck: their physicochemical characteristics and interaction with human serum albumin,” Food and Function, vol. 9, no. 4, pp. 2490–2495, 2018. View at Publisher · View at Google Scholar · View at Scopus
  28. M. B. Bolattin, S. T. Nandibewoor, S. D. Joshi, S. R. Dixit, and S. A. Chimatadar, “Interaction of hydralazine with human serum albumin and effect of β-cyclodextrin on binding: insights from spectroscopic and molecular docking techniques,” Industrial and Engineering Chemistry Research, vol. 55, no. 19, pp. 5454–5464, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Micsonai, F. Wien, L. Kernya et al., “Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 24, pp. E3095–E3103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Shahabadi, S. Hadidi, and Z. M. Kalar, “Biophysical studies on the interaction of platinum(II) complex containing antiviral drug ribavirin with human serum albumin,” Journal of Photochemistry and Photobiology. B, vol. 160, pp. 376–382, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Rabbani-Chadegani and Z. Hajihassan, “The effect of mitoxantrone as an anticancer drug on hepatocytes nuclei and chromatin: Selective release of histone proteins,” Indian Journal of Pharmacology, vol. 43, no. 2, pp. 187–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Hong and Q. Cheng, “Sensitive voltammetric determination of mitoxantrone by using CS-dispersed graphene modified glassy carbon electrodes,” Advances in Chemical Engineering and Science, vol. 02, no. 04, pp. 453–460, 2012. View at Publisher · View at Google Scholar
  33. P. D. Ross and S. Subramanian, “Thermodynamics of protein association reactions: forces contributing to stability,” Biochemistry, vol. 20, no. 11, pp. 3096–3102, 1981. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Biedermann, V. D. Uzunova, O. A. Scherman, W. M. Nau, and A. de Simone, “Release of high-energy water as an essential driving force for the high-affinity binding of cucurbit[n]urils,” Journal of the American Chemical Society, vol. 134, no. 37, pp. 15318–15323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. K. Azad, J. X. Huang, M. A. Cooper et al., “Structure–activity relationships for the binding of polymyxins with human α-1-acid glycoprotein,” Biochemical Pharmacology, vol. 84, no. 3, pp. 278–291, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. I. L. de Redín, C. B. María, C. Martínez-Ohárriz et al., “Human serum albumin nanoparticles for ocular delivery of bevacizumab,” International Journal of Pharmaceutics, vol. 541, no. 1-2, pp. 214–223, 2018. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Wang, Q. Jiang, L. R. Liu, and Q. Zhang, “The interaction between bovine serum albumin and the self-aggregated nanoparticles of cholesterol-modified O-carboxymethyl chitosan,” Polymer, vol. 48, no. 14, pp. 4135–4142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Chen, D. Wu, W. Zhong et al., “Evaluation of the PEG density in the PEGylated chitosan nanoparticles as a drug carrier for curcumin and mitoxantrone,” Nanomaterials, vol. 8, no. 7, pp. 486–4142, 2018. View at Publisher · View at Google Scholar · View at Scopus
  39. G. A. Ilevbare, H. Liu, K. J. Edgar, and L. S. Taylor, “Effect of binary additive combinations on solution crystal growth of the poorly water-soluble drug, ritonavir,” Crystal Growth and Design, vol. 12, no. 12, pp. 6050–6060, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Yang, J. Liu, Y. Huang et al., “Domain-specific interactions between MLN8237 and human serum albumin estimated by STD and WaterLOGSY NMR, ITC, spectroscopic, and docking techniques,” Scientific Reports, vol. 7, no. 1, pp. 45514–45525, 2017. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Shcharbin, E. Pedziwiatr-Werbicka, T. Serchenya et al., “Role of cationic carbosilane dendrons and metallic core of functionalized gold nanoparticles in their interaction with human serum albumin,” International Journal of Biological Macromolecules, vol. 118, no. Part B, pp. 1773–1780, 2018. View at Publisher · View at Google Scholar · View at Scopus
  42. D. M. Dhoke, S. S. Basaiyye, and P. B. Khedekar, “Development and characterization of L-HSA conjugated PLGA nanoparticle for hepatocyte targeted delivery of antiviral drug,” Journal of Drug Delivery Science and Technology, vol. 47, pp. 77–94, 2018. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Wu, J. Yan, J. Wang, Q. Wang, and H. Li, “Characterisation of interaction between food colourant allura red AC and human serum albumin: multispectroscopic analyses and docking simulations,” Food Chemistry, vol. 170, pp. 423–429, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Ràfols, S. Zarza, and E. Bosch, “Molecular interactions between some non-steroidal anti-inflammatory drugs (NSAID’s) and bovine (BSA) or human (HSA) serum albumin estimated by means of isothermal titration calorimetry (ITC) and frontal analysis capillary electrophoresis (FA/CE),” Talanta, vol. 130, pp. 241–250, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Sharma, M. Ashaduzzaman, M. Golabi, A. Shriwastav, K. Bisetty, and A. Tiwari, “Studies on bacterial proteins corona interaction with saponin imprinted ZnO nanohoneycombs and their toxic responses,” ACS Applied Materials & Interfaces, vol. 7, no. 43, pp. 23848–23856, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. D. OWENSIII and N. PEPPAS, “Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles,” International Journal of Pharmaceutics, vol. 307, no. 1, pp. 93–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. M. V. Zyuzin, Y. Yan, R. Hartmann et al., “Role of the protein corona derived from human plasma in cellular interactions between nanoporous human serum albumin particles and endothelial cells,” Bioconjugate Chemistry, vol. 28, no. 8, pp. 2062–2068, 2017. View at Publisher · View at Google Scholar · View at Scopus
  48. V. H. Nguyen, N. M. Meghani, H. H. Amin et al., “Modulation of serum albumin protein corona for exploring cellular behaviors of fattigation-platform nanoparticles,” Colloids and Surfaces B Biointerfaces, vol. 170, pp. 179–186, 2018. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Rimac, Ž. Debeljak, M. Bojić, and L. Miller, “Displacement of drugs from human serum albumin: from molecular interactions to clinical significance,” Current Medicinal Chemistry, vol. 24, no. 18, pp. 1930–1947, 2017. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Wrobel, M. Marcinkowska, A. Janaszewska et al., “Influence of core and maltose surface modification of PEIs on their interaction with plasma proteins-human serum albumin and lysozyme,” Colloids and Surfaces. B, Biointerfaces, vol. 152, pp. 18–28, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Montet, K. Montet-Abou, F. Reynolds, R. Weissleder, and L. Josephson, “Nanoparticle imaging of integrins on tumor cells,” Neoplasia, vol. 8, no. 3, pp. 214–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. S. N. dos Santos, S. R. Rezende Dos Reis, L. P. Pires et al., “Avoiding the mononuclear phagocyte system using human albumin for mesoporous silica nanoparticle system,” Microporous and Mesoporous Materials, vol. 251, pp. 181–189, 2017. View at Publisher · View at Google Scholar · View at Scopus